{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:49:57Z","timestamp":1783036197055,"version":"3.54.6"},"reference-count":35,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"unspecified","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023290","name":"W\u00f6rwag Pharma GmbH & Co. KG","doi-asserted-by":"crossref","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100023290","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Diab Res Care"],"accepted":{"date-parts":[[2026,1,11]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Shunting of glycolytic intermediates into the pentose phosphate pathway via transketolase activation by benfotiamine has been suggested to protect from hyperglycemia-induced microvascular damage, but the long-term effects of benfotiamine on diabetic sensorimotor polyneuropathy (DSPN) remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Research design and methods<\/jats:title>\n                    <jats:p>This 1:1 randomized double-blind, placebo-controlled parallel group monocentric phase II trial compared the efficacy and safety of 1-year treatment with benfotiamine 300\u2009mg two times per day versus placebo over 12 months in participants with type 2 diabetes and mild-to-moderate symptomatic DSPN. The primary endpoint was the change in corneal nerve fiber length (CNFL) assessed by corneal confocal microscopy (CCM) from baseline to 12 months. Secondary endpoints included three other CCM parameters, skin biopsy (four parameters), nerve conduction studies (13 measures), quantitative sensory testing (six parameters), cardiovascular autonomic function tests (17 indices), sudomotor function tests (five parameters), 15 clinical scores and scales for neuropathic symptoms and signs and 13 health-related quality of life and depression instruments. Pharmacokinetics included measurement of six thiamine analytes in blood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 57 participants underwent randomization. The changes from baseline to 12 months in CNFL did not differ between the two groups. The corresponding changes in the secondary morphometric, functional and clinical neuropathic outcomes as well as quality of life were also similar in the two groups. Only the Neuropathy Symptom Score tended to improve after benfotiamine treatment (p=0.098 vs placebo). Benfotiamine treatment increased the concentrations of all six thiamine analytes studied (p\u22640.003 vs placebo). Safety analysis showed no relevant differences between the groups in the rates of adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In type 2 diabetes individuals with mild-to-moderate symptomatic DSPN, treatment with benfotiamine for 12 months was well tolerated, but had no significant effects on multiple morphometric, neurophysiological and clinical measures of neuropathy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      European Clinical Trials Database (EudraCT) 2017-003054-16 registered on April 10 (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/eudract.ema.europa.eu\/\">https:\/\/eudract.ema.europa.eu\/<\/jats:ext-link>\n                      ), 2018 and German Register for Clinical Trials DRKS00014832 registered on August 3, 2018 (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/drks.de\/search\/de\">https:\/\/drks.de\/search\/de<\/jats:ext-link>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjdrc-2025-005773","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T14:00:24Z","timestamp":1769090424000},"page":"e005773","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Effects of benfotiamine treatment over 12 months on morphometric, neurophysiological and clinical measures in type 2 diabetes patients with symptomatic polyneuropathy: a randomized, placebo-controlled, double-blind clinical trial (BOND study)"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8956-3552","authenticated-orcid":false,"given":"Dan","family":"Ziegler","sequence":"first","affiliation":[{"name":"Institute for Clinical Diabetology, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at Heinreich Heine University, D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7638-0638","authenticated-orcid":false,"given":"Gundega","family":"Sipola","sequence":"additional","affiliation":[{"name":"Institute for Clinical Diabetology, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at Heinreich Heine University, D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Strom","sequence":"additional","affiliation":[{"name":"Institute for Clinical Diabetology, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at Heinreich Heine University, D\u00fcsseldorf, Germany"},{"name":"German Center for Diabetes Research (DZD e.V.), Partner D\u00fcsseldorf, Munich-Neuherberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6636-1373","authenticated-orcid":false,"given":"Klaus","family":"Strassburger","sequence":"additional","affiliation":[{"name":"German Center for Diabetes Research (DZD e.V.), Partner D\u00fcsseldorf, Munich-Neuherberg, Germany"},{"name":"Institute for Biometrics and Epidemiology, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at Heinrich Heine University, D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luise","family":"Jander","sequence":"additional","affiliation":[{"name":"Institute for Biometrics and Epidemiology, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at Heinrich Heine University, D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2050-093X","authenticated-orcid":false,"given":"Christian","family":"Herder","sequence":"additional","affiliation":[{"name":"Institute for Clinical Diabetology, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at Heinreich Heine University, D\u00fcsseldorf, Germany"},{"name":"German Center for Diabetes Research (DZD e.V.), Partner D\u00fcsseldorf, Munich-Neuherberg, Germany"},{"name":"Department of Endocrinology and Diabetology, Medical Faculty and University Hospital, Heinrich Heine University, D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5575-4315","authenticated-orcid":false,"given":"Birgit","family":"Knebel","sequence":"additional","affiliation":[{"name":"German Center for Diabetes Research (DZD e.V.), Partner D\u00fcsseldorf, Munich-Neuherberg, Germany"},{"name":"Institute for Clinical Biochemistry and Pathobiochemistry, German Diabetes Center (DDZ), Leibniz Institute for Diabetes Research at Heinrich Heine University, D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3234-6987","authenticated-orcid":false,"given":"Claudia","family":"Reule","sequence":"additional","affiliation":[{"name":"W\u00f6rwag Pharma GmbH & Co. KG, B\u00f6blingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin Assad","family":"Jaghutriz","sequence":"additional","affiliation":[{"name":"W\u00f6rwag Pharma GmbH & Co. KG, B\u00f6blingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8153-7428","authenticated-orcid":false,"given":"Andrea Carolina","family":"Moreira Tupac Yupanqui","sequence":"additional","affiliation":[{"name":"W\u00f6rwag Pharma GmbH & Co. KG, B\u00f6blingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4882-969X","authenticated-orcid":false,"given":"Andrea","family":"Icks","sequence":"additional","affiliation":[{"name":"German Center for Diabetes Research (DZD e.V.), Partner D\u00fcsseldorf, Munich-Neuherberg, Germany"},{"name":"Institute for Health Services Research and Health Economics, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at Heinrich Heine University, D\u00fcsseldorf, Germany"},{"name":"Institute for Health Services Research and Health Economics, Centre for Health and Society, Medical Faculty and University Hospital, Heinrich Heine University, D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2543-0130","authenticated-orcid":false,"given":"Hadi","family":"Al-Hasani","sequence":"additional","affiliation":[{"name":"German Center for Diabetes Research (DZD e.V.), Partner D\u00fcsseldorf, Munich-Neuherberg, Germany"},{"name":"Institute for Clinical Biochemistry and Pathobiochemistry, German Diabetes Center (DDZ), Leibniz Institute for Diabetes Research at Heinrich Heine University, D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8200-6382","authenticated-orcid":false,"given":"Michael","family":"Roden","sequence":"additional","affiliation":[{"name":"Institute for Clinical Diabetology, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at Heinreich Heine University, D\u00fcsseldorf, Germany"},{"name":"German Center for Diabetes Research (DZD e.V.), Partner D\u00fcsseldorf, Munich-Neuherberg, Germany"},{"name":"Department of Endocrinology and Diabetology, Medical Faculty and University Hospital, Heinrich Heine University, D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3301-5869","authenticated-orcid":false,"given":"Oliver","family":"Kuss","sequence":"additional","affiliation":[{"name":"German Center for Diabetes Research (DZD e.V.), Partner D\u00fcsseldorf, Munich-Neuherberg, Germany"},{"name":"Institute for Biometrics and Epidemiology, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at Heinrich Heine University, D\u00fcsseldorf, Germany"},{"name":"Centre for Health and Society, Medical Faculty and University Hospital, Heinrich Heine University, D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1446-6592","authenticated-orcid":false,"given":"Gidon J","family":"B\u00f6nhof","sequence":"additional","affiliation":[{"name":"Institute for Clinical Diabetology, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at Heinreich Heine University, D\u00fcsseldorf, Germany"},{"name":"German Center for Diabetes Research (DZD e.V.), Partner D\u00fcsseldorf, Munich-Neuherberg, Germany"},{"name":"Department of Endocrinology and Diabetology, Medical Faculty and University Hospital, Heinrich Heine University, D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"2026012206001047000_14.1.e005773.1","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-2042"},{"key":"2026012206001047000_14.1.e005773.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109063"},{"key":"2026012206001047000_14.1.e005773.3","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-024-01041-y"},{"key":"2026012206001047000_14.1.e005773.4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.diabres.2018.02.043","article-title":"Painful and painless neuropathies are distinct and largely undiagnosed entities in subjects participating in an educational initiative (PROTECT study)","volume":"139","author":"Ziegler","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"2026012206001047000_14.1.e005773.5","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/jdi.13267","article-title":"Polyneuropathy is inadequately treated despite increasing symptom intensity in individuals with and without diabetes (PROTECT follow-up study)","volume":"11","author":"Ziegler","year":"2020","journal-title":"J Diabetes Investig"},{"key":"2026012206001047000_14.1.e005773.6","doi-asserted-by":"publisher","DOI":"10.1038\/nm834"},{"key":"2026012206001047000_14.1.e005773.7","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M600418200"},{"key":"2026012206001047000_14.1.e005773.8","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.860"},{"key":"2026012206001047000_14.1.e005773.9","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2015.00351","article-title":"Benfotiamine upregulates antioxidative system in activated BV-2 microglia cells","volume":"9","author":"Bozic","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"2026012206001047000_14.1.e005773.10","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-17399"},{"key":"2026012206001047000_14.1.e005773.11","doi-asserted-by":"crossref","DOI":"10.2174\/1871527320666210825112240","article-title":"The Role of Biofactors in Diabetic Microvascular Complications","volume":"18","author":"Ziegler","year":"2022","journal-title":"Curr Diabetes Rev"},{"key":"2026012206001047000_14.1.e005773.12","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-0531"},{"key":"2026012206001047000_14.1.e005773.13","article-title":"Benfotiamine counteracts smoking-induced vascular dysfunction in healthy smokers","volume":"2012","author":"Stirban","year":"2012","journal-title":"Int J Vasc Med"},{"key":"2026012206001047000_14.1.e005773.14","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/s-0029-1211460","article-title":"A benfotiamine-vitamin B combination in treatment of diabetic polyneuropathy","volume":"104","author":"Stracke","year":"1996","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2026012206001047000_14.1.e005773.15","doi-asserted-by":"publisher","DOI":"10.5414\/CPP43071"},{"key":"2026012206001047000_14.1.e005773.16","first-page":"220","article-title":"Effectiveness of different benfotiamine dosage regimens in the treatment of painful diabetic neuropathy","volume":"49","author":"Winkler","year":"1999","journal-title":"Arzneimittelforschung"},{"key":"2026012206001047000_14.1.e005773.17","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1065351"},{"key":"2026012206001047000_14.1.e005773.18","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-057142","article-title":"BOND study: a randomised double-blind, placebo-controlled trial over 12 months to assess the effects of benfotiamine on morphometric, neurophysiological and clinical measures in patients with type 2 diabetes with symptomatic polyneuropathy","volume":"12","author":"B\u00f6nhof","year":"2022","journal-title":"BMJ Open"},{"key":"2026012206001047000_14.1.e005773.19","doi-asserted-by":"publisher","DOI":"10.2337\/db12-0574"},{"key":"2026012206001047000_14.1.e005773.20","doi-asserted-by":"crossref","first-page":"107757","DOI":"10.1016\/j.jdiacomp.2020.107757","article-title":"Treatment with benfotiamine in patients with diabetic sensorimotor polyneuropathy: A double-blind, randomized, placebo-controlled, parallel group pilot study over 12\u202fmonths","volume":"34","author":"Stirban","year":"2020","journal-title":"J Diabetes Complications"},{"key":"2026012206001047000_14.1.e005773.21","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-1895"},{"key":"2026012206001047000_14.1.e005773.22","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-1895"},{"key":"2026012206001047000_14.1.e005773.23","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-2479"},{"key":"2026012206001047000_14.1.e005773.24","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4438-5"},{"key":"2026012206001047000_14.1.e005773.25","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s00125-015-3609-5","article-title":"Overexpression of cutaneous mitochondrial superoxide dismutase in recent-onset type 2 diabetes","volume":"58","author":"Ziegler","year":"2015","journal-title":"Diabetologia"},{"key":"2026012206001047000_14.1.e005773.26","doi-asserted-by":"publisher","DOI":"10.2337\/db13-1444"},{"key":"2026012206001047000_14.1.e005773.27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/jns.12641","article-title":"Corneal confocal microscopy detects early nerve regeneration after pharmacological and surgical interventions: Systematic review and meta-analysis","volume":"29","author":"Gad","year":"2024","journal-title":"J Peripher Nerv Syst"},{"key":"2026012206001047000_14.1.e005773.28","doi-asserted-by":"publisher","DOI":"10.2337\/diab.44.12.1355"},{"key":"2026012206001047000_14.1.e005773.29","doi-asserted-by":"publisher","DOI":"10.1007\/BF00400697"},{"key":"2026012206001047000_14.1.e005773.30","doi-asserted-by":"crossref","first-page":"112224","DOI":"10.1016\/j.diabres.2025.112224","article-title":"Diagnostic performance of graded tuning fork vibration thresholds as a stand-alone test and within clinical assessments of diabetic neuropathy","volume":"224","author":"B\u00f6nhof","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"2026012206001047000_14.1.e005773.31","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-0503"},{"key":"2026012206001047000_14.1.e005773.32","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.812370","article-title":"COVID-19 Pandemic and Trends in Clinical Trials: A Multi-Region and Global Perspective","volume":"8","author":"Nishiwaki","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"2026012206001047000_14.1.e005773.33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/nyas.14536","article-title":"Thiamine deficiency disorders: a clinical perspective","volume":"1498","author":"Smith","year":"2021","journal-title":"Ann N Y Acad Sci"},{"key":"2026012206001047000_14.1.e005773.34","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16155","article-title":"Thiamine deficiency-related neuropathy: A reversible entity from an endemic area","volume":"31","author":"Nisar","year":"2024","journal-title":"Eur J Neurol"},{"key":"2026012206001047000_14.1.e005773.35","doi-asserted-by":"crossref","first-page":"155565","DOI":"10.1016\/j.metabol.2023.155565","article-title":"Association between diabetes and thiamine status - A systematic review and meta-analysis","volume":"144","author":"Ziegler","year":"2023","journal-title":"Metab Clin Exp"}],"container-title":["BMJ Open Diabetes Research &amp; Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjdrc-2025-005773","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T14:00:28Z","timestamp":1769090428000},"score":1,"resource":{"primary":{"URL":"https:\/\/drc.bmj.com\/lookup\/doi\/10.1136\/bmjdrc-2025-005773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,22]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1136\/bmjdrc-2025-005773"],"URL":"https:\/\/doi.org\/10.1136\/bmjdrc-2025-005773","relation":{},"ISSN":["2052-4897"],"issn-type":[{"value":"2052-4897","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}